Stocks
Biosolution and Merck Life Science Unveil Joint Technologies at CPHI Korea 2026
Biosolution, a South Korean biopharmaceutical company, has partnered with Merck Life Science to showcase their joint technologies at CPHI Korea 2026. The exhibition was held from August 25 to 27 at COEX in Samseong-dong, Seoul.
The joint booth featured Biosolution's human-derived 3D tissue models, including its flagship product 'KeraSkin', as well as Merck Life Science's research and analytical instruments such as the 'Millicell ERS 3.0' and 'MILLIPLEX'.
Lee Su-hyun, Head of Preclinical Research Center at Biosolution, explained that their booth introduced an integrated animal testing alternative solution covering the entire research process.